Edap Tms (NASDAQ:EDAP) Stock Rating Upgraded by StockNews.com

StockNews.com upgraded shares of Edap Tms (NASDAQ:EDAP) from a sell rating to a hold rating in a report issued on Wednesday morning.

Separately, HC Wainwright reissued a buy rating and set a $19.00 price target on shares of Edap Tms in a research report on Thursday, August 29th.

Edap Tms Stock Performance

Shares of Edap Tms stock opened at $2.81 on Wednesday. The company has a market cap of $104.26 million, a PE ratio of -5.20 and a beta of 0.43. The company has a quick ratio of 1.80, a current ratio of 2.45 and a debt-to-equity ratio of 0.03. Edap Tms has a 52 week low of $2.71 and a 52 week high of $8.50. The business has a 50 day moving average price of $3.84 and a 200-day moving average price of $5.52.

Edap Tms (NASDAQ:EDAP) last released its quarterly earnings results on Wednesday, August 28th. The medical equipment provider reported ($0.18) EPS for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.04). The company had revenue of $16.97 million during the quarter, compared to analysts’ expectations of $17.16 million. Edap Tms had a negative net margin of 31.68% and a negative return on equity of 36.41%. Equities analysts anticipate that Edap Tms will post -0.59 earnings per share for the current fiscal year.

Institutional Trading of Edap Tms

A number of hedge funds have recently bought and sold shares of EDAP. Roubaix Capital LLC bought a new position in Edap Tms in the 1st quarter valued at $169,000. Miracle Mile Advisors LLC purchased a new position in shares of Edap Tms in the 1st quarter worth about $136,000. Virtu Financial LLC purchased a new position in shares of Edap Tms in the 1st quarter worth about $82,000. Finally, Commonwealth Equity Services LLC grew its position in Edap Tms by 5.9% during the second quarter. Commonwealth Equity Services LLC now owns 71,260 shares of the medical equipment provider’s stock valued at $388,000 after buying an additional 4,000 shares during the period. 62.74% of the stock is currently owned by institutional investors.

Edap Tms Company Profile

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments.